Literature DB >> 16148850

Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era.

Nava Buznach1, Ron Dagan, David Greenberg.   

Abstract

BACKGROUND: Acute conjunctivitis is the most common eye disorder in young children. Bacteria are responsible for 54-73% of all cases. The goals of the study were to identify the rates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis in cases of bacterial conjunctivitis in children and to define antibiotic resistance rates.
METHODS: During a 2-year study period, conjunctival swabs of children 2-36 months old were collected prospectively. Nontypable H. influenzae, S. pneumoniae and M. catarrhalis were defined as the study pathogens. Analyzed variables included demography, clinical presentation, bacteriologic results and susceptibility patterns.
RESULTS: There were 428 patients enrolled. Of all cultures, 55% (237 of 428) yielded at least 1 of the study pathogens. H. influenzae and S. pneumoniae were isolated from 29 and 20% of cultures, respectively. beta-Lactamase production was found in 29% of H. influenzae isolates, and penicillin nonsusceptibility was observed in 60% of S. pneumoniae isolates. The most common S. pneumoniae serotypes were: 19F (14%); 6A and 14 (11% each). Nontypable S. pneumoniae was found in 12%. The 7-valent pneumococcal conjugate vaccine (PCV-7) could potentially cover 44% of all isolates. Conjunctivitis-otitis syndrome was found in 32% of patients, of whom 82% of cultures yielded H. influenzae.
CONCLUSIONS: Antibiotic resistance rates are alarmingly high. Conjunctivitis-otitis syndrome, predominantly caused by H. influenzae, is quite common. The potential coverage of the PCV-7 in conjunctivitis is relatively lower than that reported in other pneumococcal infections. Our findings should alert physicians on the choice of appropriate antibiotic treatment, on the frequent copresence of acute otitis media and on the potential role of conjunctivitis in the spread of antibiotic-resistant pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148850     DOI: 10.1097/01.inf.0000178066.24569.98

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  31 in total

Review 1.  Bacterial conjunctivitis.

Authors:  John Epling
Journal:  BMJ Clin Evid       Date:  2012-02-20

Review 2.  Bacterial conjunctivitis.

Authors:  John Epling
Journal:  BMJ Clin Evid       Date:  2010-03-15

3.  Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells.

Authors:  Rachel Balder; Thomas M Krunkosky; Chi Q Nguyen; Lacey Feezel; Eric R Lafontaine
Journal:  Infect Immun       Date:  2009-08-10       Impact factor: 3.441

4.  Assessment of Streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection.

Authors:  Erin W Norcross; Nathan A Tullos; Sidney D Taylor; Melissa E Sanders; Mary E Marquart
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

5.  An assessment of the tolerability of moxifloxacin 0.5% compared to azithromycin 1.0% in DuraSite.

Authors:  David Granet; Steven J Lichtenstein; Bruce Onofrey; James A Katz
Journal:  Clin Ophthalmol       Date:  2007-12

6.  Effectiveness, tolerability and safety of azithromycin 1% in DuraSite for acute bacterial conjunctivitis.

Authors:  Susannah McLean; Aziz Sheikh
Journal:  Patient Prefer Adherence       Date:  2010-05-13       Impact factor: 2.711

7.  Detection of cryptic genospecies misidentified as Haemophilus influenzae in routine clinical samples by assessment of marker genes fucK, hap, and sodC.

Authors:  Niels Nørskov-Lauritsen
Journal:  J Clin Microbiol       Date:  2009-06-17       Impact factor: 5.948

8.  Microbiological profile of bacterial conjunctivitis in ibadan, Nigeria.

Authors:  A O Okesola; A O Salako
Journal:  Ann Ib Postgrad Med       Date:  2010-06

Review 9.  Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing.

Authors:  Kari Lee Visscher; Cindy M L Hutnik; Mary Thomas
Journal:  Can Fam Physician       Date:  2009-11       Impact factor: 3.275

10.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.